Renalogic News

US Supreme Court Validates Self-Funded Health Plans’ Rights to Use Cost Containment

Media Release

CHICAGO, IL (June 22, 2022) –On June 21, 2022, the U.S. Supreme Court published its decision in Marietta Memorial Hospital, et al. v. DaVita, et al. In this decision, the Supreme Court ruled that self-funded health plans have the authority under the Medicare Secondary Payor Act (MSPA) to carve out dialysis benefits and set rates for such benefits at appropriate levels for plans and their members. In reaching its decision, the Supreme Court relied on the reasoning in the Amy’s Kitchen case, cementing Renalogic’s ImpactProtect cost containment program as the market-leading, most legally sound methodology for dialysis cost containment.




The kidney dialysis market is dominated by two large, multi-national companies: DaVita and Fresenius. Because of their dominance and lack of viable competition, dialysis rates billed to commercial health plans have ballooned by roughly 400% since 2008.


Marietta was one of five federal cases launched by DaVita in late 2018 – early 2019 against commercial health plans and other organizations.  In this lawsuit, DaVita argued that a commercial health plan does not have the legal authority to carve out dialysis benefits and pay dialysis claims differently from other types of claims under the MSPA.  In contrast, Marietta Hospital and the US Department of Justice argued that the MSPA was designed to coordinate benefits between insurance plans and Medicare for individuals covered by both, and not to provide preferential status to dialysis claims or individuals needing dialysis.


Marietta Hospital won in the trial court, while the Sixth Circuit Court of Appeals reversed the trial court’s decision, holding for DaVita.  The Supreme Court agreed to hear the case to settle the issue because of its importance and because the Ninth Circuit Court of Appeals reached an opposite decision than that of the Sixth Circuit in the landmark Amy’s Kitchen case. In Amy’s Kitchen, the Ninth Circuit categorically supported health plans’ authority to carve out dialysis benefits and approved Renalogic’s claims repricing methodology, ImpactProtect.


The Supreme Court’s Marietta Ruling


In Marietta, the Supreme Court ruled in Marietta Hospital’s favor, reversing the Sixth Circuit’s decision.  The Supreme Court firmly established that health plans have the authority under the MSPA to carve out dialysis benefits and recalibrate the cost of dialysis claims to levels more appropriate for plans and their members.  In reaching its decision, the Court looked to the Amy’s Kitchen case for guidance and support, clearly establishing Renalogic and its ImpactProtect cost containment program as the leader in the market with the most legally sound methodology.



About Renalogic

Founded in 2002, Renalogic helps self-funded plans of all sizes and their U.S-based health plan members reduce the human and financial costs of chronic kidney disease (CKD) and dialysis treatment. We help plans manage dialysis claims costs and work to prevent members from progressing to dialysis. Through our cost containment and population health management solutions, Renalogic is 230% better than commercial plans at identifying undiagnosed CKD, 86% effective at preventing members from kidney failure and delivers 84.5% average savings off contracted rates with our claims repricing. We’ve saved our clients over $780,000,000 and helped stop CKD from progressing for thousands of members.